3-吡啶甲腈,1,2-二氢-6-(4-甲氧苯基)-2-羰基- | 147269-06-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 3-吡啶甲腈,1,2-二氢-6-(4-甲氧苯基)-2-羰基-
• 英文名称: 6-(4-methoxyphenyl)pyrid-2-one-3-carbonitrile
• 英文别名: 6-(4-methoxyphenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile；6-(4-methoxyphenyl)-2-oxo-1H-pyridine-3-carbonitrile
• CAS: 147269-06-5
• 化学式: C₁₃H₁₀N₂O₂
• mdl: MFCD00215116
• 分子量: 226.235
• InChiKey: YJDWXUFFZLKITF-UHFFFAOYSA-N

物化性质

• 沸点：
  466.3±45.0 °C(Predicted)
• 密度：
  1.27±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.076
• 拓扑面积：
  62.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-吡啶甲腈,1,2-二氢-6-(4-甲氧苯基)-2-羰基- 在 N-溴代丁二酰亚胺(NBS) 、 三氯氧磷 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 5-Bromo-2-chloro-6-(4-methoxy-phenyl)-nicotinonitrile
  参考文献：
  名称：

  6-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)

  摘要：

  A novel series of 6-aryl-pyrazolo[3,4-b]pyridines has been identified that are potent inhibitors of glycogen synthase kinase-3 (GSK-3).(C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(03)00645-0
• 作为产物：
  描述：

  对甲氧基苯乙酮 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 反应 15.0h， 生成 3-吡啶甲腈,1,2-二氢-6-(4-甲氧苯基)-2-羰基-
  参考文献：
  名称：

  ANTIVIRAL COMPOUNDS

  摘要：

  一个化合物可以包含公式1的结构、其衍生物、前药、盐、立体异构体、互变异构体、多晶型或溶剂化物，或者在任何手性中心具有任何手性：R1包括氢或取代基；R2包括羟基、形成羟基的前药或离开羟基的化学基团；R3包括卤素；R4包括杂环。该化合物可以是一种用于抗病毒治疗的抗病毒化合物。

  公开号：

  US20210238210A1

文献信息

• Heterocyclic amides
  申请人：Zeneca Limited

  公开号：US05521179A1

  公开（公告）日：1996-05-28

  The present invention relates to certain novel heterocyclic amides which are 1-pyridylacetamide compounds of formula I, set out herein, which are inhibitors of human leukocyte elastase (HLE), also known as human neutrophil elastase (HNE), making them useful whenever such inhibition is desired, such as for research tools in pharmacological, diagnostic and related studies and in the treatment of diseases in mammals in which HLE is implicated. The invention also includes intermediates useful in the synthesis of these heterocyclic amides, processes for preparing the heterocyclic amides, pharmaceutical compositions containing such heterocyclic amides and methods for their use.

  本发明涉及某些新颖的杂环酰胺，它们是式I所示的1-吡啶乙酰胺化合物，这些化合物是人类白细胞弹性蛋白酶（HLE）的抑制剂，也被称为人类中性粒细胞弹性蛋白酶（HNE），使它们在需要这种抑制作用时非常有用，例如用作药理学、诊断和相关研究工具以及治疗哺乳动物中HLE相关疾病。该发明还包括在合成这些杂环酰胺过程中有用的中间体，制备这些杂环酰胺的方法，含有这些杂环酰胺的药物组合物以及它们的使用方法。
• Is the Herbicidal Activity of 3-Cyanopyridin-2-yl Phosphates Related to Phosphatase?
  作者：Ping Wei、Qi Hui、Xin-Ying Zhang、Li-Min Yu、Miao Wang、Yi-Xiang Ding

  DOI：10.1080/10426500802514442

  日期：2009.10.13

  The herbicidal activity of 3-cyanopyridin-2-yl phosphates, which were designed according to the idea of a mechanism-based inactivator, is probably related to a phosphatase.

  根据基于机制的灭活剂的思想设计的 3-氰基吡啶-2-基磷酸酯的除草活性可能与磷酸酶有关。
• Heterocyclic amides having HLE inhibiting activity
  申请人：ZENECA LIMITED

  公开号：EP0509769A2

  公开（公告）日：1992-10-21

  The present invention relates to certain novel heterocyclic amides which are 1-pyridylacetamide compounds of formula I, set out herein, which are inhibitors of human leukocyte elastase (HLE), also known as human neutrophil elastase (HNE), making them useful whenever such inhibition is desired, such as for research tools in pharmacological, diagnostic and related studies and in the treatment of diseases in mammals in which HLE is implicated. The invention also includes intermediates useful in the synthesis of these heterocyclic amides, processes for preparing the heterocyclic amides, pharmaceutical compositions containing such heterocyclic amides and methods for their use.

  本发明涉及某些新型杂环酰胺，它们是式I的1-吡啶基乙酰胺化合物，载于本发明中，它们是人白细胞弹性蛋白酶（HLE），也称为人中性粒细胞弹性蛋白酶（HNE）的抑制剂，使得它们在任何需要这种抑制的情况下都有用，例如在药理学、诊断学和相关研究中用作研究工具，以及在治疗哺乳动物中涉及HLE的疾病时。本发明还包括用于合成这些杂环酰胺的中间体、制备杂环酰胺的工艺、含有这些杂环酰胺的药物组合物及其使用方法。
• Synthesis of the pyridone analogues of territrem B
  作者：Yinghua Yang、Lianli Sun、Shengyi Dong、Xiaoyu Wang、Leixiang Yang、Xiumei Wu、Hua Bai、Yu Zhao

  DOI：10.1016/j.mencom.2008.07.004

  日期：2008.7

  Two series of territrem B analogues were synthesised in nine linear steps from commercially available starting materials.
• Discovery and structure–activity relationships study of novel thieno[2,3-b]pyridine analogues as hepatitis C virus inhibitors
  作者：Ning-Yu Wang、Wei-Qiong Zuo、Ying Xu、Chao Gao、Xiu-Xiu Zeng、Li-Dan Zhang、Xin-Yu You、Cui-Ting Peng、Yang Shen、Sheng-Yong Yang、Yu-Quan Wei、Luo-Ting Yu

  DOI：10.1016/j.bmcl.2014.01.075

  日期：2014.3

  Current treatment for hepatitis C is barely satisfactory, there is an urgent need to develop novel agents for combating hepatitis C virus infection. This study discovered a new class of thieno[ 2,3-b] pyridine derivatives as HCV inhibitors. First, a hit compound characterized by a thienopyridine core was identified in a cell-based screening of our privileged small molecule library. And then, structure activity relationship study of the hit compound led to the discovery of several potent compounds without obvious cytotoxicity in vitro (12c, EC50 = 3.3 mu M, SI > 30.3, 12b, EC50 = 3.5 mu M, SI > 28.6, 10l, EC50 = 3.9 mu M, SI > 25.6, 12o, EC50 = 4.5 mu M, SI > 22.2, respectively). Although the mechanism of them had not been clearly elucidated, our preliminary optimization of this class of compounds had provided us a start point to develop new anti-HCV agents. (C) 2014 Elsevier Ltd. All rights reserved.